Article
Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial.
Trials - 1 May 2020
Deng Chao, Lou Yanni, Gao Yu, Deng Bo, Su Fei, Jia Liqun
Abstract excerpt
BACKGROUND: Diarrhea is a common adverse reaction in patients with cancer receiving chemotherapy, for which there is currently no effective method of treatment. Shengjiang Xiexin decoction (SXD), a classic traditional Chinese medicine (TCM) formula, has shown efficacy in alleviating irinotecan-induced diarrhea in preliminary clinical studies. The current study is designed to assess the efficacy and safety of SXD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
